BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27463482)

  • 21. Glucocorticoid-induced TNFR-related protein (GITR) ligand modulates cytokine release and NK cell reactivity in chronic lymphocytic leukemia (CLL).
    Buechele C; Baessler T; Wirths S; Schmohl JU; Schmiedel BJ; Salih HR
    Leukemia; 2012 May; 26(5):991-1000. PubMed ID: 22064350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.
    Giannoni P; Marini C; Cutrona G; Matis S; Capra MC; Puglisi F; Luzzi P; Pigozzi S; Gaggero G; Neri A; Todoerti K; Morabito F; Ibatici A; Miglino M; Bergamaschi M; Bruno S; Sambuceti GM; Ravetti JL; Ferrarini M; Fais F; de Totero D
    Haematologica; 2021 Oct; 106(10):2598-2612. PubMed ID: 32855274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimized mitogen stimulation induces proliferation of neoplastic B cells in chronic lymphocytic leukemia: significance for cytogenetic analysis.The Tampere Chronic Lympocytic Leukemia group.
    Larramendy ML; Siitonen SM; Zhu Y; Hurme M; Vilpo L; Vilpo JA; Knuutila S
    Cytogenet Cell Genet; 1998; 82(3-4):215-21. PubMed ID: 9858820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant chronic lymphocytic leukemia B cells express interleukin 2 receptors but fail to respond to interleukin 2's proliferative signal.
    Perri RT; Kay NE
    Leukemia; 1987 Feb; 1(2):127-30. PubMed ID: 3118104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
    Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
    Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukemia.
    Luo HY; Rubio M; Biron G; Delespesse G; Sarfati M
    J Immunother (1991); 1991 Dec; 10(6):418-25. PubMed ID: 1768675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
    Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
    Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tumor necrosis factor-α and interleukin-10 levels as markers to predict outcome of patients with chronic lymphocytic leukemia in different risk groups defined by the IGHV mutation status.
    Lech-Maranda E; Grzybowska-Izydorczyk O; Wyka K; Mlynarski W; Borowiec M; Antosik K; Cebula-Obrzut B; Makuch-Lasica H; Nowak G; Klimkiewicz-Wojciechowska G; Wawrzyniak E; Bilinski P; Robak T; Warzocha K
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):477-86. PubMed ID: 22945689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of TNF, IL-6 and sCD23 correlate with changes in lymphocyte count in patients with B-cell chronic lymphocytic leukaemia receiving interferon-alpha therapy.
    Jewell AP; Worman CP; Giles FJ; Goldstone AH
    Leuk Lymphoma; 1997 Jan; 24(3-4):327-33. PubMed ID: 9156662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.
    Uckun FM; Fauci AS; Chandan-Langlie M; Myers DE; Ambrus JL
    J Clin Invest; 1989 Nov; 84(5):1595-608. PubMed ID: 2681271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exogenous interleukin 2 (IL 2) reconstitutes deficient in vitro T-cell growth of patients with chronic lymphocytic leukemia of B-cell lineage (B-CLL).
    Jehn U; Gross HJ; Wachholz K; Pauls R
    Anticancer Res; 1990; 10(4):929-34. PubMed ID: 2382990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: a new role for TNF alpha?
    Sivaraman S; Deshpande CG; Ranganathan R; Huang X; Jajeh A; O'Brien T; Huang RW; Gregory SA; Venugopal P; Preisler HD
    Microsc Res Tech; 2000 Aug; 50(3):251-7. PubMed ID: 10891891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
    Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
    Büssing A; Stein GM; Stumpf C; Schietzel M
    Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
    Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
    Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-alpha, Bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia.
    Jewell AP
    Leuk Lymphoma; 1996 Mar; 21(1-2):43-7. PubMed ID: 8907268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.